#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)


March 31, 2020 — The Intelligent Evaluation System of chest computed tomography (CT) for COVID-19, developed by YITU under the guidance of Shanghai Public Health Clinical Center, was officially launched and was put into the first-line battle against COVID-19 pandemic on Jan. 28. It is the first AI-equipped diagnostic assistant, which significantly improves efficiency in identifying coronavirus through automatic detection and quantitative analysis within 2-3 seconds, and eases the burden of Chinese doctors.

YITU Healthcare reinforced its R&D capability with multi-departments cooperation right after the outbreak of the pandemic and released its cutting-edge AI diagnosis system, with upgrades on a daily basis during the Chinese New Year. YITU assisted many designated medical institutions and supported the frontline heroes fighting the pandemic.

According to its official public account of Shanghai Public Health Clinical Center, one of the authoritative institutions in the field of infectious diseases in China and the key unit for the treatment of COVID-19 in Shanghai, an article titled "AI Aids the Scientific Prevention and Control, Intelligent Evaluation System for COVID-19 Launched in Shanghai Public Health Clinical Center", announced its latest achievements in using artificial intelligence technology to help doctors carry out quantitative analysis and evaluation of therapeutic efficacy of new coronavirus lesions based on CT images.

COVID-19 Diagnosis and Treatment Plan (Trial Version 7) issued by the General Office of the National Health Commission of the People's Republic of China stipulates that CT imaging results should be used as one of the criteria for the diagnosis of COVID-19 nationwide. At the same time, based on clinical experience, the CT imaging performance of COVID-19 is further clarified and the quantitative evaluation of CT images is incorporated into the clinical classification basis.

YITU's AI-driven solution of intelligent diagnosis and quantitative evaluation of CT images of COVID-19, are through industry-leading image algorithms, and grade the severity of various pneumonia diseases of local lesions, diffuse lesions, and whole lung involvement. Furthermore, it accurately quantifies the cumulative pneumonia load of the disease through quantitative and omics analysis of key image features such as the morphology, range, and density of the lesion, and achieves a dynamic 4-D contrast of the lung lesions on the CT, helping in clinical judgment of the condition, evaluation of the efficacy, and prediction of the prognosis.

Taking up the challenge and responsibility in response to frontline needs and requests, YITU's Intelligent Evaluation System of Chest CT for COVID-19 has been adopted across 25 provinces and municipal autonomous prefectures in 100 medical institutions and served over 100,000 person-times in China by far.

For more information: www.yitutech.com

Related Coronavirus Content:

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...

Time November 17, 2025
arrow
News | Radiology Imaging

Nov. 13, 2025 — Medical imaging AI company Avicenna.AI has launched AVI, a new platform that delivers AI results ...

Time November 13, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Orthopedic Imaging

Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...

Time November 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Nov. 10, 2025 — There has been substantial progress in the past few years in the field of MRI in general and remote MR ...

Time November 11, 2025
arrow
News | RSNA 2025

Nov. 7, 2025 — Coreline Soft will introduce its chest AI platform AVIEW 2.0 at RSNA 2025 (Nov. 30 – Dec. 4, Chicago) ...

Time November 10, 2025
arrow
News | Contrast Media

Nov. 10, 2025 — Scientists at the University of Birmingham have developed a new class of MRI contrast agents – improving ...

Time November 10, 2025
arrow
Feature | Teleradiology | Kyle Hardner

Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...

Time November 06, 2025
arrow
Subscribe Now